Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Circulating Biomarkers”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06141993
What this trial is testing

ARCTIC: Liquid Biomarkers in the Prospective Androgen Receptor Signaling Inhibitors (ARSI) Resistance Clinical Trials

Who this might be right for
Prostate CancerProstate AdenocarcinomaProstate Cancer Metastatic+1 more
Duke University 120
Not applicableStudy completedNCT02499458
What this trial is testing

Prospective Validation of Circulating Tumor Cells & Circulating Endothelial Cells as Biomarkers in Renal Cancer

Who this might be right for
Clear Cell Renal CancerCirculating Tumor CellsCirculating Endothelial Cells+2 more
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 44
Not applicableNot Yet RecruitingNCT07833891
What this trial is testing

Senocohort: Identification of Predictive Biomarkers in Breast Cancer Treatment

Who this might be right for
Breast CancerBreast Cancer (Triple Negative Type)
Assistance Publique - Hôpitaux de Paris 500
Not applicableNot Yet RecruitingNCT06649838
What this trial is testing

Customized Circulating Tumor DNA Testing for Cervical Cancer Recurrence Surveillance and Treatment Decisions

Who this might be right for
ImmunotherapyCervical CancerCtDNA+1 more
Peking Union Medical College Hospital 60
Not applicableUnknownNCT05536843
What this trial is testing

Clinical, Translational and Biomarker-Based Female Genital HPV Induced Dysplasia and Cancer Screening Study Using Cf-HPV-DNA Blood Tests

Who this might be right for
Cervical Dysplasia, UterineVaginal DysplasiaVulvar Dysplasia
University of Mississippi Medical Center 500
Not applicableEnded earlyNCT04523389
What this trial is testing

Contents of Circulating Extracellular Vesicles: Biomarkers in Colorectal Cancer Patients

Who this might be right for
Colorectal Cancer
Centre Hospitalier Universitaire Dijon 172
Not applicableStudy completedNCT00862290
What this trial is testing

Circulating microRNAs as Biomarkers of Sepsis

Who this might be right for
Sepsis
Changhai Hospital 100
Not applicableUnknownNCT03302884
What this trial is testing

Circulating Tumor DNA as an Early Marker of Recurrence and Treatment Efficacy in Ovarian Carcinoma

Who this might be right for
Ovarian Carcinoma
Institut Paoli-Calmettes 150
Not applicableStudy completedNCT02992080
What this trial is testing

Small Circulating RNA as Molecular Markers of Lung Disease in Cystic Fibrosis

Who this might be right for
Cystic Fibrosis
University Hospital, Montpellier 80
Not applicableUnknownNCT05705583
What this trial is testing

A Companion Diagnostic Study to Develop Circulating Exosomes as Predictive Biomarkers for the Response to Immunotherapy in Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Zhejiang Cancer Hospital 100
Not applicableUnknownNCT05279599
What this trial is testing

Application of Circulating Extracellular Vesicles in Early Disease Assessment and Prognosis After Traumatic Brain Injury

Who this might be right for
Traumatic Brain Injury
Tang-Du Hospital 300
Not applicableUnknownNCT04315753
What this trial is testing

Circulating and Imaging Biomarkers to Improve Lung Cancer Management and Early Detection

Who this might be right for
Lung Cancer
Istituto Clinico Humanitas 2,000
Not applicableStudy completedNCT00603057
What this trial is testing

Using Imaging and Molecular Markers to Predict Tumor Response and Lung Toxicity in Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
University of Michigan Rogel Cancer Center 115
Not applicableUnknownNCT05486988
What this trial is testing

CtDNA as a Biomarker for Treatment in Advanced NSCLC

Who this might be right for
Non-small Cell Lung Cancer
Fuzhou General Hospital 500
Not applicableStudy completedNCT05750303
What this trial is testing

Potential Prognostic Markers of Recovery in Post-stroke Rehabilitation

Who this might be right for
Ischemic Stroke
Medical University of Lodz 32
Not applicableLooking for participantsNCT06967961
What this trial is testing

Research of Double-positive Circulating Cells (Tumor Marker / CD45+) in Several Types of Metastatic Cancers

Who this might be right for
Urothelial CarcinomaRenal CancerProstate Adenocarcinoma+7 more
Institut Claudius Regaud 450
Not applicableLooking for participantsNCT05965557
What this trial is testing

Exploration of Predictive Markers of Neoadjuvant Immunotherapy in Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Geneplus-Beijing Co. Ltd. 100
Not applicableStudy completedNCT02109575
What this trial is testing

Quantitative Detection of Circulating Donor-Specific DNA in Organ Transplant Recipients (DTRT-Multi-Center Study)

Who this might be right for
Cardiovascular DiseaseAcute Rejection of Cardiac TransplantCardiac Transplant Rejection+1 more
Medical College of Wisconsin 540
Not applicableLooking for participantsNCT04493723
What this trial is testing

Serial Tumour Biopsies and Blood Biomarkers in Melanoma

Who this might be right for
Melanoma
The Christie NHS Foundation Trust 300
Not applicableNot Yet RecruitingNCT07821554
What this trial is testing

Personalised Nutritional Care in Older Patients With Pancreatic Ductal Adenocarcinoma

Who this might be right for
Pancreatic Cancer
Inna Chen, MD 250
Next Page